# Clover Health ($CLOV) • Expected Adjusted EBITDA Profitable as of FY 2024. • Levered free cash flow positive with almost no debt. • Over $417M of cash on balance sheet. Parent entity and unregulated subsidiaries have an additional $137M of cash. • 7.48% insider ownership. • Over $5 revenue per share for a company with shares trading at $0.80. • Cash on hand exceeds market cap. • Extremely low institutional ownership (\~25%). • Clover Assistant helps doctors diagnose early signs of disease such that they can treat patients more effectively and patients avoid getting sicker. Healthier patients means lower need to pay out. Better patient outcomes at a lower overall cost. • Counterpart Assistant is a $CLOV SaaS that makes the company able to offer their software to other Mediacare Advatage healthcare providers. $CLOV has the potential to become the AWS of Medicare Advantage. • •  --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://xponentialfinance.gitbook.io/xponential-finance/investments/stocks/clover-health-usdclov.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.